Valeant Pharmaceuticals' fourth-quarter loss widened to $515 million versus $385 million in the same period of 2015, as sales dropped 13 percent year-over-year to $2.4 billion, the company reported Tuesday.
Pfizer received two subpoenas from the US Attorney’s office in Massachusetts related to charities that help Medicare patients afford co-payments for drugs, Bloomberg reported